Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Tesseract Medical Research

Request full access

Tesseract - Preventative & Nutritional Supplementation

Napa, United StatesFounded 2016Biotech & Life Sciences

About Tesseract Medical Research

Tesseract Medical Research, founded in 2016 by Al Czap, is a life sciences company focused on advancing health through nutraceuticals. Czap, who previously founded and led Thorne Research, established Tesseract with the goal of overcoming common obstacles in nutrient supplementation, such as low bioavailability and poor tolerance. His experience in creating pure, allergen-free formulations at Thorne set the stage for his work at Tesseract, where he continues to address the challenge of delivering beneficial molecules effectively.

The company operates in the nutraceutical and medical food markets, serving both healthcare practitioners and consumers directly. Its business model centers on the development and sale of supplements that utilize a proprietary, patent-pending nutrient delivery system. In 2023, Tesseract acquired the tolling and operations business from Pulse Combustion Systems, a move intended to give it greater control over its manufacturing processes, which are crucial for its core business. This vertical integration reflects a strategy to manage and scale the production of its specialized products.

Tesseract's core offering is its advanced delivery technology, which enhances the absorption of active ingredients. This system involves a two-step process named CyLoc® and DexKey®. First, the CyLoc® technology encases individual molecules of an ingredient in a dextrin fiber matrix, protecting them through the digestive system and masking any unpalatable taste or odor. Then, the DexKey® process facilitates the release of the active ingredient at the desired point in the intestinal tract for optimal absorption. This allows for lower, more effective doses, a concept the company refers to as micro-dosing. Products incorporating this technology include ProButyrate® for gastrointestinal health, QuerciSorb™ for immune response, and AuRx®, a medical food developed for individuals on the Autism Spectrum.

Source: Dealroom company data

At a glance

Status
Operational
Employees
6
Open positions
None listed
Dealroom signal
78.2/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SEED✓Equity / VC Jun 2024 $20M $80M Geding Venture Capital · Chengwei Capital · Curie.Bio ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Tesseract Medical Research website traffic

Latest recorded traffic for Tesseract Medical Research is 4.9K monthly website visits, up 28.9% over the last three months. Tesseract Medical Research's team grew 0% over the past year.

Latest monthly visits4.9K 3-month web change+28.9% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Tesseract Medical Research in the Napa ecosystem

Live from Dealroom

The Tesseract Medical Research office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • Geding Venture Capital
  • Chengwei Capital
  • Curie.Bio
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Tesseract Medical Research on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tesseract Medical Research’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.